top of page




Throughout our 125-year history, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas. Our commitment to our people, partners, stakeholders and, most importantly, our patients remains as strong as it was on the first day of our journey. We focus on finding new medicines and diagnostics and establishing data-based insights that evolve the practice of medicine and help patients live longer, better lives.


PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. Our mission is to provide access to best-in-class treatments for patients with little to no treatment options. For 25 years, we have been successful delivering on our mission by pursuing groundbreaking science and technology to bring multiple innovative therapies that are transforming patient’s lives, globally.Everything we've done, every study, every experiment, every investment is made first and foremost to change the course of rare diseases and the lives of our patients. To learn more about PTC, please visit us at and follow us on Instagram, Facebook, Twitter, and LinkedIn.

genpharm new logo.png

At Genpharm, our mantra is clear – Bringing Cures To MENAT Patients. Genpharm is a pharmaceutical market access company focused on niche therapeutics and diagnostics for rare diseases and specialty. We provide fast and sustainable market access solutions into the MENAT (Middle East, North Africa, and Turkey) region to our strategic partners. We act as the exclusive regional commercial partner for pharmaceutical pioneers in the MENAT. Our expertise is maintained through our cross-functional departments such as Medical Affairs, PV, Regulatory, Quality, Logistics, and more. We provide strategic advice and solutions on Business Development opportunities as well as pathway for companies evaluating their entry into MENAT. We are proud to be the first company to successfully introduce gene therapy in the MENAT region.


CMRC is a specialized Rehabilitation Hospital and Long-term care provider in the MENA Region. At Cambridge Medical and Rehabilitation Center, we provide specialized rehabilitation hospital setup and dedicated medical care and rehabilitation services to patients requiring short-term comprehensive rehabilitation and long-term care for patients with chronic illness or injury. We deliver a superior level of service tailored to meet the individual treatment needs of every patient in our care and encourage family members’ involvement in the patient’s treatment plan.



We put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. Our partners collaborate with us because of our reputation for quality, our strong brand recognition, and our US FDA-inspected manufacturing plants. Organisations we work with know they can rely on us to deliver consistently, in all our markets. We have always been committed to high standards of ethical conduct. In our business and in our dealings with other people. At the heart of this are our three values: Innovation. Caring. Collaboration. These shape the way our people think, work and behave. And ensure the sustainability of our company. In 2017, we achieved the highest ranking of any pharmaceutical company in the UK’s Institute of Directors' Good Governance Report.


We are focused on creating genuinely innovative medicines and improving access to them. In this way, we deliver the greatest benefit to patients, healthcare systems and societies globally. We have three priorities designed to deliver our growth through innovation strategy. Accelerate Innovative Science: Accelerating the next wave of new molecular entities, building our capabilities in immunology and rare diseases, pursuing new scientific modalities and driving R&D productivity Deliver Growth and Therapy Area Leadership: Meeting our growth and profitability goals through successful innovation and commercial excellence, as well as completing the Alexion acquisition Be a Great Place to Work: Contributing to the enterprise and to society, with a focus on inclusion and diversity, lifelong learning, improving access to healthcare, environmental protection, and ethics and transparency, as well as delivering our Ambition Zero Carbon program. Inspired by our Values and what science can do, we are focused on accelerating the delivery of life-changing medicines that create enduring value for patients and society. We are committed to operating in a way that recognizes the interconnection between business growth, the needs of society and the limitations of our planet.

Pfizer (2).png

We’re in relentless pursuit of breakthroughs that change patients’ lives. We innovate every day to make the world a healthier place. It was Charles Pfizer's vision at the beginning and it holds true today. Our unique resources allow us to do more for people. Using our global presence and scale, we’re able to make a difference in local communities and the world around us. We advance medical innovation and distribute medicines that might not otherwise be available to underserved communities.


SANOFI - new.png

We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our teams across the world strive to transform the practice of medicine, turning the impossible into the possible for patients. We provide potentially life-changing treatments and the protection of life-saving vaccines to millions of people, and affordable access to our medicines in some of the world’s poorest countries.

NOVARTIS (2).png

About Novartis Novartis is reimagining medicine to improve and extend people’s lives. We deliver high-value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. About 103,000 people of more than 140 nationalities work together to bring Novartis products to nearly 800 million people around the world. Find out more at Novartis is on Twitter. Sign up to follow @Novartis at For Novartis multimedia content, please visit For questions about the site or required registration, please contact


Established in 1990, MetroMed is a pioneer among UAE healthcare distributors, known for its professional excellence and reputation as one of the region’s medicale marketing partners of choice. Headquartered in Dubai, MetroMed is a company of Mazrui International LLC, a privately-held diversified conglomerate with operations across numerous industries and asset classes in the MENA region. The Mazrui International group of companies are market leaders in several sectors including Oil & Gas, Construction & Building Materials, Retail, Industrial, and Healthcare. Each Mazrui International company benefits from a world-class support structure delivered through a Shared Services model. Know more about Mazrui International. MetroMed supplies pharmaceutical products, medical devices and equipment, consumer healthcare, and veterinary products to pharmacies, government and private hospitals, supermarkets, and veterinary clinics throughout the United Arab Emirates. Know more about veterinary products. Backed by decades of regional experience, our company has been consistent in creating a valuable market presence for our partner brands and delivering above-average market share growth. As a result, we foster long term partnerships and associations and are regarded as a specialty distributor of choice boasting a valuable product portfolio and an ever-expanding list of new partners.


Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and specialty care. The group develops and commercializes innovative medicines in three key therapeutic areas – Oncology, Neuroscience and Rare Diseases. Its commitment to Oncology is exemplified through its growing portfolio of key therapies for prostate cancer, neuroendocrine tumors, renal cell carcinoma and pancreatic cancer. Ipsen also has a well-established Consumer Healthcare business. With total sales over €2.2 billion in 2018, Ipsen sells more than 20 drugs in over 115 countries, with a direct commercial presence in more than 30 countries. Ipsen’s R&D is focused on its innovative and differentiated technological platforms located in the heart of the leading biotechnological and life sciences hubs (Paris-Saclay, France; Oxford, UK; Cambridge, US). The Group has about 5,700 employees worldwide. Ipsen is listed in Paris (Euronext: IPN) and in the United States through a Sponsored Level I American Depositary Receipt program (ADR: IPSEY). For more information on Ipsen.


AbbVie was founded in 2013 when we became a separate company from Abbott. Our name represents a proud connection to that legacy. AbbVie formed a new kind of enterprise – a biopharmaceutical company – with the stability, global scale, resources and commercial capabilities of a pharmaceutical company and the focus and culture of a biotech. Since the beginning, our mission hasn't wavered. Our combination of focused innovation and commercial scale brings differentiated products to market that benefit patients, customers and health care providers. Our mission is to discover and deliver innovative medicines and products that solve serious health issues and enhance people’s lives today and address the medical challenges of tomorrow.


Discover PHARMALINK Exemplifying the Best-In-Class healthcare provisions made accessible to the GCC region. Our Purpose is to offer the missing link to essential and high-quality healthcare innovation and value-added services which address emerging unmet medical needs and help more patients live healthier and happier lives. Our Aspiration is to solidify PHARMALINK’s presence as the number one healthcare provider in the region by 2030 if not before.


Noubel Rehabilitation Center is a leading provider of high-quality rehabilitation services for individuals who have experienced physical injury, illness or disability. Our team of experienced healthcare professionals is dedicated to help our clients achieve their rehabilitation goals, using evidence-based treatments and personalized care plans. With a focus on promoting independence and maximizing function, we strive to empower our clients to live their best lives. At Noubel Rehabilitation Center, we are committed to delivering compassionate, comprehensive care to each and every person we serve.


Realize a better Prosthetic & Orthotic Experience Xtremity Prosthetics and Orthotics is a specialized health clinic where treatment is provided by a specialized team which comprises allied health professionals as well as medical professionals giving a multidisciplinary approach towards prosthetic and orthotic rehabilitation care. During the current evolution of digital era, we thrive to maintain and embrace the digital transformation in our specialized care. Our service includes the utilization of the latest cutting-edge technology i.e., 3D printing, and CAD-based production, which helps us to serve the children and adult population, with functionally enhanced Orthoses and Prostheses. This in turn not only raises the quality of the product but also enhances the overall standard of the Prosthetic and Orthotic market in the country.


Transforming Lives Through Genetic Discovery Over two decades ago when we first opened our doors, we focused on giving much-needed attention to the underserved communities of those with rare diseases. These rare disease communities mostly affected children and were often ignored. At the time, BioMarin developed the only treatments for these life-altering conditions, giving hope to patients and families. Throughout our history, we’ve worked tirelessly to make a difference by pursuing bold science while respecting, educating, and connecting with patients. Through our expertise in genetics and molecular biology, we have been able to develop targeted therapies that address the root cause of the exact conditions we seek to treat. Our discoveries have led us to countless breakthroughs, best-in-class treatments and many ‘firsts’ in the category. We are grateful to able to better the lives of those struggling with genetic diseases. As we look forward, we strive to make an even greater impact by applying the same science-driven, patient-forward approach to a broader range of genetic disorders. The more innovative solutions we develop, the more lives we can impact. This isn’t just our passion, it’s our purpose.



Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while advancing a healthier, more sustainable and equitable world. Founded in 1978, Biogen has pioneered multiple breakthrough innovations including a broad portfolio of medicines to treat multiple sclerosis, the first approved treatment for spinal muscular atrophy, and two co-developed treatments to address a defining pathology of Alzheimer’s disease.


Our journey, which started in Turkey in 2013, continues with our offices in Istanbul, Dubai and now Ghana. Currently, we deliver our products and services to approximately 20 countries, and we maintain our physical presence in 12 of these countries. We are growing rapidly with more than 100 employees who are competent in their fields, and we combine our innovative business approaches with medical experience, with the experience of more than a hundred years of experience of our doctors and pharmacists in our team. Our journey that started with medicine continues with the inclusion of non-pharmaceutical health solutions. With our partners in various countries of the world, we provide a wide range of services covering all areas from diagnosis to treatment. Our cooperation philosophy is based on transparency and coexistence within the framework of common goals, guided by our expertise. As TRPHARM, our mission that we have been loyal to since the first day is to bring together innovative solutions with health. Our vision, which we have created with our years of experience, is to be a global, innovative healthcare company. Our values that we take as a guide in each of our steps are to be in life, collaboration, balance and transformation.


At Avernus Pharma, we are working together to help patients around the world by changing the way disease is treated. The journey towards solving the big problems that will help people live fuller lives through a personalized treatment approaches. We recognize the unique responsibility we hold to not only provide top-quality care to our customers, but to serve as role models for corporate responsibility and societal advancement for these areas. Positively impacting the lives of our patients and communities along with customer satisfaction at large is not only our promise, but our privilege. Avernus Pharma has managed to support our global partners to expand their business across the GCC with the expertise of talented and specialized teams as well as by avoiding supply chain disruptions and distribution obstacles, ensuring ongoing development of novel treatments for patients. We are condent that, together with our Global partners, we have the right people to achieve our milestones, and more importantly, the milestones of our customers.


We have been pioneering nutritional solutions since 1896, when our founders first began their early support of mothers and their infants. Since then, our nutritional solutions have transformed the lives of millions of people around the world. That pioneering spirit lives on today with an ongoing commitment to provide life-transforming nutrition at key moments throughout life.

bottom of page